Predicting the risk of restenosis after angioplasty in patients with peripheral arterial disease

Clinical Laboratory

Volumn 47, Issue 11-12, 2001, Pages 555-559

  Roller, R E ^a   Schnedl, W J ^a   Korninger, C ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Angioplasty; Atherosclerosis; CRP; Fibrinogen; Homocysteine; Lp(a); Migration inducing activity; PAI 1; Restenosis; vWF

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; FIBRINOGEN; HOMOCYSTEINE; LIPOPROTEIN A; PLASMINOGEN ACTIVATOR INHIBITOR 1; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER;

AMINO ACID BLOOD LEVEL; ANTIGEN DETECTION; ARTERY DISEASE; CELL MIGRATION; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENDER; HUMAN; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; RESTENOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; BLOOD; PERIPHERAL VASCULAR DISEASE; PROGNOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY RESTENOSIS; HUMAN; PERIPHERAL VASCULAR DISEASES; PROGNOSIS; RISK FACTORS;

EID: 0035179299     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Femoral and popliteal arteries: Reanalysis of results of balloon angioplasty
2. Novel approaches for the prevention of restenosis
3. Time course of cellular proliferation, intimal hyperplasia, and remodelling following angioplasty in monkeys with established atherosclerosis
4. Pathobiology of intimal hyperplasia
5. Regulatory functions of the coronary endothelium
6. Prediction of restenosis after coronary balloon angioplasty. Results of PICTURE (Post-Intracoronary Treatment Ultrasound Re-Evaluation), a prospective multicenter intracoronary ultrasound imaging study
7. Prediction of restenosis after coronary angioplasty by use of a new index: TIMI frame count/minimal luminal diameter ratio
8. Surgical transluminal iliac angioplasty with selective stenting: Long term results assessed by means of duplex scanning
9. Intravascular ultrasound predictors of restenosis after balloon angioplasty of the femoropopliteal artery
10. Ultrasonic plaque character and outcome after lower limb angioplasty
11. Value of lesion morphology and of residual stenosis in predicting late clinical outcomes and restenosis rate post- PTCA in single-vessel disease
12. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Antagonism (CARPORT) study group
13. Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes mellitus
14. Restenosis and progression of coronary disease after balloon angioplasty in patients with diabetes mellitus
15. Fibrinogen as a cardiovascular risk factor: A metaanalysis and review of the literature
16. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty
17. Fibrinogen after coronary angioplasty as a risk factor for restenosis
18. Plasma fibrinogen as a risk factor for restenosis after percutaneous transluminal renal angioplasty in patients with atherosclerotic renal artery stenosis
19. Prospective study of hemostatic risk factors and incidence of coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) study
20. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly. Results from the Cardiovascular Health Study
21. Von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis
22. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease
23. Endogenous tissue-type plasminogen activator and risk of myocardial infarction
24. Fibrin, D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischemic heart disease in the Caerphilly Study
25. Changes of the fibrinolytic system in PAOD patients during angioplasty
26. A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis
27. Impaired fibrinolysis determines the outcome of percutaneous transluminal angioplasty (PTCA)
28. The role of lipoprotein(a) in atherosclerosis and thrombosis
29. Lipoprotein Lp(a) excess and coronary heart disease
30. Lipoprotein [Lp(a)] and peripheral vascular disease
31. Elevated lipoprotein(a) and increased incidence of restenosis during femoropopliteal PTA. Rationale for the higher risk of recurrence in females?
32. Lipoprotein (a) level does not predict restenosis after percutaneous transluminal coronary angioplasty
33. Impaired homocysteine metabolism and atherothrombotic disease
34. Hyperhomocysteinemia, atherosclerosis and thrombosis
35. Blood levels of homocysteine and increased risks of cardiovascular disease. Causal or casual?
36. Homocysteine as a risk factor for restenosis after coronary angioplasty
37. Hyperhomocysteinemia and restenosis
38. Homocysteine, lipoproteine (a), and restenosis after percutaneous transluminal coronary angioplasty: A prospective study
39. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease
40. In vitro study of vascular endothelial injury by activated platelets and its prevention
41. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
42. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty
43. Response of atherosclerotic intimal smooth muscle cells to epidermal growth factor in vitro
44. Basic fibroblast growth factor: Its role in the control of smooth muscle cell migration
45. The proliferation of neointimal smooth muscle cells cultured from rabbit aortic explants 15 weeks after de-endothelialization by a balloon catheter
46. Insulin-like growth factor binding protein-1 inhibits arterial smooth muscle cell proliferation in vitro but does not reduce the neointimal response to balloon catheter injury
47. Platelets and restenosis
48. Mechanims underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results
49. A polymorphism of glycoprotein IIb/IIIa receptor as an inherited risk factor for coronary thrombosis
50. The PIA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with peripheral arterial disease
51. Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening predictors of peripheral arterial disease
52. Coronary angioplasty induces a systemic inflammatory response
53. Raised interleukin 6 concentrations as a predictor of postangioplasty restenosis
54. Serum levels of circulating adhesion molecules after coronary angioplasty
55. Smooth muscle cell migration is stimulated by plasma of patients with peripheral arterial occlusive disease undergoing angioplasty